A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Table 1

Summary of perioperative outcomes from notable series for primary and postchemotherapy R-RPLND.

Primary RPLND
Group	Year	N	CS I	CS II	Operative time (mins)	EBL (ml)	Lymph node yield	LOS (days)	Complication rate (%)	Positive lymph nodes (%)	Recurrence-free rate (%)	Antegrade ejaculation (%)	Follow-up (months)
Harris et al. [26]	2015	16	16	0	294	75	22	—	6.3	12.5	—	100	13.5
Cheney et al. [32]	2015	10	9	1	311	100	22	2.75	—	30	80	91	22
Stepanian et al. [23]	2016	16	11	5	293	50	19.5	1	5	38	100	90	49
Pearce et al. [6]	2017	47	42	5	235	50	26	1	14	17	97	96	16
Postchemo RPLND
Group	Year	N	CS I	CS II	Operative time (mins)	EBL (ml)	Lymph node yield	LOS (days)	Complication rate (%)	Positive lymph nodes (%)	Recurrence-free rate (%)	Antegrade ejaculation (%)	Follow-up (months)
Cheney et al. [32]	2015	8	7	1	369	313	18	2.2	—	62.5	100	—	22
Stepanian et al. [23]	2016	4	1	3	324	150	22	1.5	—	50	100	100	41
Kamel et al. [12]	2016	12	6	6	312	475	22	3	25	50	100	66.7	31

LOS = length of stay; EBL = estimated blood loss; CS = clinical stage.